Tilsotolimod and Yervoy Combo Seen to Shrink Tumors in Pre-treated Metastatic Melanoma Patients in Ongoing Phase 2 Trial
A combination of Idera Pharmaceuticals’s treatment candidate…
Myeloma
Myeloma overview
Myeloma is a rare blood cancer that begins in plasma cells, a type of white blood cell normally responsible for producing antibodies that help fight off infectious pathogens and other threats.
Read moreMyeloma treatment
While myeloma treatment can drive the disease into remission, sometimes for long periods of time, the cancer will often come back after a few months or years, and additional treatments will be needed.
Read moreLatest news
Janssen Halts Clinical Trials of Darzalex with PD-1/PD-L1 Inhibitors Amid Concerns Over Safety, Effectiveness
Janssen has decided to discontinue a Phase 1 trial…
Trial Data Supports Darzalex Combo as Potentially Effective in Myeloma Patients Who Don’t Respond to Revlimid
A combination of Darzalex (daratumumab) plus Kyprolis (carfilzomib)…
Canadian Researchers Launch Study to Make Stem Cell Transplants Safer, More Efficient
Researchers in Canada are studying how to reduce the…
MS Therapy May Ease Painful Side Effect of Velcade Treatment in Myeloma Patients, Study Says
A multiple sclerosis (MS) treatment reduced a common…
